PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 56 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | -100.0% | 2,185 | +9.2% | 0.00% | – |
Q2 2022 | $1,000 | -66.7% | 2,000 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | -40.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
Q3 2021 | $6,000 | -45.5% | 2,000 | -32.3% | 0.00% | – |
Q2 2021 | $11,000 | -8.3% | 2,956 | -13.9% | 0.00% | – |
Q1 2021 | $12,000 | +9.1% | 3,435 | +6.5% | 0.00% | – |
Q4 2020 | $11,000 | +57.1% | 3,224 | +59.4% | 0.00% | – |
Q3 2020 | $7,000 | -30.0% | 2,023 | -5.1% | 0.00% | – |
Q2 2020 | $10,000 | -44.4% | 2,131 | -27.0% | 0.00% | – |
Q4 2019 | $18,000 | – | 2,921 | +41628.6% | 0.00% | – |
Q2 2019 | $0 | – | 7 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|